Clinical Trial Update: A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluated the effect of safinamide on levodopa pharmacokinetics in idiopathic Parkinson's disease; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• Safinamide (Safinamide)

Snippet

Sponsor: Newron Pharmaceuticals SPA | Conditions: Idiopathic Parkinson's Disease | Phase 1, Phase 2 | Status: COMPLETED